Phytohealth Corp
PhytoHealth Corporation researches, develops, manufactures, and sells medicines, cosmetics, Class B medicines, complementary foods, and other related products in Taiwan. It operates in three segments: Medicines and Health Food, Medical Diagnosis, and Precision Medical Equipment and Instruments. The Medicines and Health Food segment manufactures and sells Chinese medicine materials and new drugs. … Read more
Phytohealth Corp (4108) - Total Assets
Latest total assets as of September 2025: NT$2.34 Billion TWD
Based on the latest financial reports, Phytohealth Corp (4108) holds total assets worth NT$2.34 Billion TWD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Phytohealth Corp - Total Assets Trend (2002–2024)
This chart illustrates how Phytohealth Corp’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Phytohealth Corp - Asset Composition Analysis
Current Asset Composition (December 2024)
Phytohealth Corp's total assets of NT$2.34 Billion consist of 53.6% current assets and 46.5% non-current assets.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0.9% |
| Accounts Receivable | NT$40.58 Million | 1.7% |
| Inventory | NT$155.89 Million | 6.4% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$35.31 Million | 1.5% |
| Goodwill | NT$31.18 Million | 1.3% |
Asset Composition Trend (2002–2024)
This chart illustrates how Phytohealth Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Phytohealth Corp's current assets represent 53.6% of total assets in 2024, an increase from 0.0% in 2002.
- Cash Position: Cash and equivalents constituted 0.9% of total assets in 2024, down from 27.3% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2002.
- Asset Diversification: The largest asset category is inventory at 6.4% of total assets.
Phytohealth Corp Competitors by Total Assets
Key competitors of Phytohealth Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Phytohealth Corp - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Phytohealth Corp generates 0.06x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Phytohealth Corp is currently not profitable relative to its asset base.
Phytohealth Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 28.66 | 34.88 | 12.44 |
| Quick Ratio | 26.02 | 31.61 | 10.49 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$1.34 Billion | NT$ 1.54 Billion | NT$ 886.02 Million |
Phytohealth Corp - Advanced Valuation Insights
This section examines the relationship between Phytohealth Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.57 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | 3.8% |
| Total Assets | NT$2.44 Billion |
| Market Capitalization | $64.47 Million USD |
Valuation Analysis
Below Book Valuation: The market values Phytohealth Corp's assets below their book value (0.03 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Phytohealth Corp's assets grew by 3.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Phytohealth Corp (2002–2024)
The table below shows the annual total assets of Phytohealth Corp from 2002 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | NT$2.44 Billion | +3.79% |
| 2023-12-31 | NT$2.35 Billion | -0.60% |
| 2022-12-31 | NT$2.36 Billion | -4.27% |
| 2021-12-31 | NT$2.47 Billion | +36.50% |
| 2020-12-31 | NT$1.81 Billion | -3.84% |
| 2019-12-31 | NT$1.88 Billion | -9.01% |
| 2018-12-31 | NT$2.07 Billion | -5.65% |
| 2017-12-31 | NT$2.19 Billion | -9.60% |
| 2016-12-31 | NT$2.42 Billion | +3.64% |
| 2015-12-31 | NT$2.34 Billion | -6.00% |
| 2014-12-31 | NT$2.49 Billion | -11.85% |
| 2013-12-31 | NT$2.82 Billion | -2.06% |
| 2012-12-31 | NT$2.88 Billion | +74.70% |
| 2011-12-31 | NT$1.65 Billion | -13.45% |
| 2010-12-31 | NT$1.91 Billion | -9.79% |
| 2009-12-31 | NT$2.11 Billion | +96.20% |
| 2008-12-31 | NT$1.08 Billion | -30.74% |
| 2007-12-31 | NT$1.56 Billion | +15.04% |
| 2006-12-31 | NT$1.35 Billion | +11.66% |
| 2005-12-31 | NT$1.21 Billion | +296.80% |
| 2004-12-31 | NT$305.18 Million | -11.31% |
| 2003-12-31 | NT$344.09 Million | +120.54% |
| 2002-12-31 | NT$156.02 Million | -- |